Contingent Value Right (CVR) — Fair Value Remeasurement
Remeasuring the fair value of a CVR liability issued to the selling shareholders of an acquired biotech company.
| Account Name | Type | Debit ($) | Credit ($) |
|---|---|---|---|
| Finance Income / Expense (CVR Remeasurement) | Expense (+) | 45,000,000.00 | - |
| CVR Liability (Fair Value) | Liability (+) | - | 45,000,000.00 |
💡 Accountant's Note
A CVR (Contingent Value Right) entitles the holder to a cash payment if the acquired drug achieves specified clinical or commercial milestones. CVRs are classified as a financial liability at fair value through profit and loss (FVTPL) under IFRS 9 — the liability is remeasured each reporting period based on updated probability of milestone achievement and drug sales projections.
Practitioner & Systems Framework
💻 ERP Architecture
CVR liabilities are maintained in the treasury module or a separate financial instruments register, separate from operating liabilities. At each reporting date, the fair value is recalculated using a probability-weighted expected payment model — the probability of each milestone being achieved is multiplied by the payment amount and discounted to present value. Changes in fair value are recognised immediately in finance income or expense (FVTPL). Clinical trial results, competitive intelligence, and regulatory decisions are the primary drivers of CVR fair value movements. Large CVR fair value changes are a major source of earnings volatility in pharma.
⚠️ Audit Flags
Auditors engage valuation specialists to independently assess the CVR fair value. The probability of milestone achievement is the most critical and subjective input — auditors test it against clinical data, regulatory guidance received, and comparable drug programmes. Confirm that the discount rate used is appropriate for the remaining milestone timeline. Review whether CVRs are listed (exchange-traded) or unlisted — for listed CVRs, the market price provides Level 1 fair value evidence. Assess whether any CVR payments made during the period were at the expected amount or triggered a gain/loss.
📄 Required Documentation
CVR agreement (milestone definitions, payment amounts, timeline), CVR fair value model (probability assumptions, discount rate, DCF output), clinical and regulatory update supporting probability assumptions, independent valuation (if material), CVR liability roll-forward (opening + remeasurement ± payments = closing), and IFRS 9 FVTPL classification assessment.
Professional Excel Template
Get the automated version of this entry. Includes built-in IFRS checks, VAT calculators, and SAP-ready upload formats.
Expert Analysis by Qusai Ahmad
General Accountant Supervisor & IFRS Specialist
Specialized in SAP GUI automation and Middle Eastern tax compliance. Building digital tools for the next generation of finance leaders.